In this study, despite the low number of CD4+T cells, no severe clinical symptoms of active toxoplasmosis (lymphadenopathy, chorioretinitis and cerebral/pulmonary manifestations) were detected in COVID-19 patients infected with high titer of T. gondii IgG. This evidence concerns the gene CD4 and toxoplasmosis.